Substance Name: Mogamulizumab [USAN:INN]
RN: 1159266-37-1
UNII: YI437801BE
Note
- A defucosylated humanized anti-CCR4 antibody under phase I clinical trials (2010).
Molecular Formulas
- C6520-H10072-N1736-O2020-S42
- Unspecified
Classification Codes
- Antineoplastic
- Antineoplastic Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Mogamulizumab [USAN:INN]
Synonyms
- Immunoglobulin G1, anti-(human C-C chemokine receptor type 4 (CCR4, K5-5, CD194)); humanized mouse monoclonal KW-0761 gamma1 heavy chain (222-219')-disulfide with humanized mouse monoclonal KW-0761 kappa light chain, dimer (228-228'':231-231'')- bisdisulfide
- KM 8761
- KM8761
- KW 0761
- KW-0761
- Mogamulizumab
- Poteligeo
- UNII-YI437801BE
Systematic Name
- Immunoglobulin G1, anti-(CC chemokine receptor CCR4) (human-mouse monoclonal KW-0761 heavy chain), disulfide with human-mouse monoclonal KW-0761 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1159266-37-1
FDA UNII
- YI437801BE
System Generated Number
- 1159266371